Atlas Trials

Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older

Clinical trial NCT02677610 · WITHDRAWN

Trial details

NCT number
NCT02677610
Sponsor
Merz North America, Inc.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Atopic Dermatitis
Primary completion
2016-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.